Hui-Ching Wang

550 total citations
5 papers, 472 citations indexed

About

Hui-Ching Wang is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Hui-Ching Wang has authored 5 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Epidemiology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Hui-Ching Wang's work include Hepatitis B Virus Studies (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Moyamoya disease diagnosis and treatment (1 paper). Hui-Ching Wang is often cited by papers focused on Hepatitis B Virus Studies (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Moyamoya disease diagnosis and treatment (1 paper). Hui-Ching Wang collaborates with scholars based in Taiwan, Russia and United States. Hui-Ching Wang's co-authors include Wenya Huang, Ming-Derg Lai, Ih‐Jen Su, Wan-Chi Lin, Ching‐Chow Chen, Wen‐Tsan Chang, Huan‐Yao Lei, Cheng‐Chan Lu, Ih‐Jen Su and Ai‐Li Shiau and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Molecular Cancer Research.

In The Last Decade

Hui-Ching Wang

4 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui-Ching Wang Taiwan	3	327	235	130	113	35	5	472
Yasutoshi Nozaki Japan	8	317 1.0×	106 0.5×	80 0.6×	167 1.5×	65 1.9×	15	535
Qinyu Xu China	5	252 0.8×	109 0.5×	32 0.2×	141 1.2×	60 1.7×	9	418
Vera J. Goh Singapore	9	173 0.5×	74 0.3×	64 0.5×	149 1.3×	23 0.7×	11	430
Morgane Mabire France	6	189 0.6×	111 0.5×	52 0.4×	49 0.4×	45 1.3×	9	364
Peipei Ren China	12	132 0.4×	81 0.3×	37 0.3×	132 1.2×	36 1.0×	19	402
Sadaharu Iio Japan	9	181 0.6×	192 0.8×	11 0.1×	151 1.3×	42 1.2×	21	436
Hanju Huang China	10	100 0.3×	79 0.3×	21 0.2×	79 0.7×	36 1.0×	24	294
Liang Da China	9	215 0.7×	31 0.1×	91 0.7×	150 1.3×	21 0.6×	13	347
H.‐J. Schlayer Germany	9	150 0.5×	181 0.8×	14 0.1×	106 0.9×	65 1.9×	13	425
Hafida Khorsi France	8	158 0.5×	226 1.0×	11 0.1×	139 1.2×	11 0.3×	12	400

Countries citing papers authored by Hui-Ching Wang

Since Specialization

Citations

This map shows the geographic impact of Hui-Ching Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Ching Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Ching Wang more than expected).

Fields of papers citing papers by Hui-Ching Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui-Ching Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Ching Wang. The network helps show where Hui-Ching Wang may publish in the future.

Co-authorship network of co-authors of Hui-Ching Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Ching Wang. A scholar is included among the top collaborators of Hui-Ching Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Ching Wang. Hui-Ching Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Yen, Chia‐Hung, Shih‐Feng Cho, Hui-Ching Wang, et al.. (2024). Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma. Oncology Letters. 29(1). 30–30. 1 indexed citations

2.

Wang, Hui-Ching, et al.. (2020). Gemcitabine/cisplatin/pembrolizumab-induced posterior reversible encephalopathy syndrome. Journal of Cancer Research and Practice. 7(3). 127–127.

3.

Hsieh, Yi‐Hsuan, Ih‐Jen Su, Hui-Ching Wang, et al.. (2007). Hepatitis B Virus Pre-S2 Mutant Surface Antigen Induces Degradation of Cyclin-Dependent Kinase Inhibitor p27Kip1 through c-Jun Activation Domain-Binding Protein 1. Molecular Cancer Research. 5(10). 1063–1072. 70 indexed citations

4.

Hung, Jui‐Hsiang, Ih‐Jen Su, Huan-Yao Lei, et al.. (2004). Endoplasmic Reticulum Stress Stimulates the Expression of Cyclooxygenase-2 through Activation of NF-κB and pp38 Mitogen-activated Protein Kinase. Journal of Biological Chemistry. 279(45). 46384–46392. 225 indexed citations

5.

Lu, Cheng‐Chan, Wen‐Chi Chen, Wei‐Jen Yao, et al.. (2001). Prevalence and Significance of Hepatitis B Virus (Hbv) Pre–S Mutants in Serum and Liver At Different Replicative Stages of Chronic Hbv Infection. Hepatology. 33(1). 277–286. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact